Atherosclerotic Vascular Disease
Understanding Atherosclerotic Vascular Disease (ASVD), also known as Arteriosclerosis, is crucial for accurate clinical documentation and medical coding. This page provides information on ASVD, including its relationship to Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Learn about diagnosis, treatment, and relevant healthcare coding terms for optimal documentation in medical records.
Hardening and narrowing of the arteries due to plaque buildup, restricting blood flow.
Chest pain, shortness of breath, leg pain, numbness, weakness, high blood pressure, high cholesterol.
Cardiologist office, primary care clinic, hospitals (cardiology, vascular surgery).
ICD-10 Code Families
Complete code families applicable to I70.90
When to use each related code
| Description | When to use |
|---|---|
| Hardening and narrowing of the arteries. | Use for conditions affecting blood flow due to plaque buildup. Include specific location (e.g., coronary, peripheral). |
| Chest pain due to reduced blood flow to the heart. | Use for angina symptoms related to coronary artery disease. Consider stable, unstable, or variant types. |
| Reduced blood flow to the limbs, usually legs. | Use for symptoms like leg pain, numbness, or cramping due to peripheral artery disease. |
Best-practice checklist
- ✓Document disease location (e.g., coronary, peripheral)
- ✓Specify disease severity (e.g., mild, moderate, severe)
- ✓Record symptoms (e.g., angina, claudication)
- ✓Note diagnostic test results (e.g., angiography, ABI)
- ✓Document risk factors (e.g., smoking, hypertension)
Common pitfalls to avoid
Coding atherosclerosis requires specifying the affected artery (e.g., coronary, carotid). Unspecified location leads to inaccurate coding and claims.
Miscoding arteriosclerosis (I70) as atherosclerosis (I70.9) is common. CDI should clarify the specific diagnosis for accurate coding.
Atherosclerosis often coexists with hypertension, diabetes, etc. Incomplete documentation of comorbidities impacts risk adjustment and reimbursement.
Best-practice tips
- 01Document atherosclerosis risk factors: smoking, diabetes, hypertension.
- 02Code atherosclerosis severity and location per ICD-10 guidelines for accurate reimbursement.
- 03Specify PAD or CAD for improved CDI and risk adjustment. Capture disease impact on ADLs.
- 04Regularly review patient medications for optimal lipid management and antithrombotic therapy.
- 05Educate patients on lifestyle changes: diet, exercise, and smoking cessation for improved outcomes.
Step-by-step checklist
- 1
Verify documented symptoms (chest pain, claudication)
- 2
Check risk factors (smoking, diabetes, hypertension)
- 3
Review imaging results (angiography, ultrasound)
- 4
Assess lipid panel (LDL, HDL, triglycerides)
Ready-to-paste narrative
Patient presents with symptoms suggestive of atherosclerotic vascular disease (ASVD). Differential diagnosis includes coronary artery disease (CAD), peripheral artery disease (PAD), and other forms of arteriosclerosis. Risk factors assessed include hyperlipidemia, hypertension, smoking history, family history of cardiovascular disease, diabetes mellitus, and age. Physical examination findings may include diminished or absent peripheral pulses, carotid bruits, abnormal cardiac auscultation, and signs of prior myocardial infarction or stroke. Diagnostic workup may include lipid panel, electrocardiogram (ECG), cardiac stress test, ankle-brachial index (ABI), angiography, and carotid ultrasound. Diagnosis of ASVD is based on clinical presentation, risk factor assessment, and diagnostic testing results. Treatment plan focuses on risk factor modification, including lifestyle changes such as diet and exercise, smoking cessation, and medication management for hypertension, hyperlipidemia, and diabetes. Pharmacological therapies may include statins, antiplatelet agents, and antihypertensive medications. Patient education regarding the importance of medication adherence, regular follow-up appointments, and recognizing signs and symptoms of acute coronary syndrome is crucial. Further evaluation and management may be required by a cardiologist or vascular specialist depending on disease severity and clinical course. This documentation supports medical billing and coding for ASVD, CAD, and PAD, as appropriate, using ICD-10 codes. The patient's progress and response to treatment will be closely monitored and documented in subsequent encounters.
Common questions and answers
How can I differentiate between stable and unstable atherosclerotic plaques in patients with suspected coronary artery disease using non-invasive imaging techniques?+
Differentiating between stable and unstable atherosclerotic plaques is crucial for risk stratification and treatment planning in patients with suspected coronary artery disease (CAD). While invasive coronary angiography remains the gold standard, non-invasive imaging modalities offer valuable insights. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can characterize plaque morphology, identifying features like thin-cap fibroatheroma (TCFA), positive remodeling, and large lipid cores, which are associated with plaque vulnerability. Coronary computed tomography angiography (CCTA) can detect high-risk plaque features such as low attenuation and spotty calcifications. Combining these imaging modalities with clinical risk factors and functional testing enhances diagnostic accuracy and can guide decisions regarding medical therapy, revascularization, or lifestyle interventions. Explore how integrating multi-modality imaging can improve risk stratification in your CAD patients.
What are the latest evidence-based guidelines for managing peripheral artery disease in patients with comorbid diabetes and chronic kidney disease?+
Managing peripheral artery disease (PAD) in patients with comorbid diabetes and chronic kidney disease presents unique challenges due to the complex interplay of these conditions. Current guidelines emphasize a multidisciplinary approach focusing on aggressive risk factor modification, including strict glycemic control, blood pressure management, lipid-lowering therapy, and smoking cessation. Optimal medical therapy includes antiplatelet agents and therapies targeting specific PAD symptoms like claudication. Revascularization procedures, such as endovascular interventions or bypass surgery, should be considered for patients with severe limb ischemia or persistent symptoms despite optimal medical therapy. Careful consideration of renal function and potential contrast-induced nephropathy is essential when planning interventions. Consider implementing a structured, multidisciplinary approach to optimize outcomes in this high-risk population. Learn more about the latest advancements in PAD management for patients with complex comorbidities.
Beyond traditional risk factors, what emerging biomarkers are showing promise for early detection and risk stratification of atherosclerotic vascular disease, including coronary and peripheral artery disease?+
While traditional risk factors like hypertension, hyperlipidemia, and diabetes provide valuable information, emerging biomarkers are showing promise for refining risk stratification and facilitating earlier detection of atherosclerotic vascular disease (ASVD), encompassing both coronary artery disease (CAD) and peripheral artery disease (PAD). Inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) have been linked to increased ASVD risk. Markers of endothelial dysfunction, such as soluble adhesion molecules, and markers of plaque instability, like lipoprotein-associated phospholipase A2 (Lp-PLA2), are also being investigated. Furthermore, advances in genetic and genomic research are identifying potential genetic markers that may contribute to ASVD susceptibility. While not yet routinely used in clinical practice, these emerging biomarkers hold potential for personalized risk assessment and targeted interventions. Explore how incorporating these biomarkers may enhance your ASVD risk assessment strategies in the future.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.